SCHEMBL1306154

SCHEMBL1306154

O=Cc1coc2c(O)c(O)ccc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 4/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ POLB P06746 1/20 0.56
▸ ALOX15 P16050 6/20 0.55
▸ ALOX12 P18054 6/20 0.55
▸ XDH P47989 1/20 0.55
▸ PFKFB3 Q16875 1/20 0.55
▸ ATP1A1 P05023 2/20 0.53
▸ ATP1B1 P05026 2/20 0.53
▸ ATP1A3 P13637 2/20 0.53
▸ ATP1B2 P14415 2/20 0.53
▸ ATP1A2 P50993 2/20 0.53
▸ ATP1B3 P54709 2/20 0.53
▸ FXYD2 P54710 2/20 0.53
▸ ATP1A4 Q13733 2/20 0.53
▸ NUDT1 P36639 1/20 0.53
▸ PIK3CA P42336 5/20 0.52
▸ HSP90AA1 P07900 1/20 0.49
▸ HSP90AB1 P08238 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29951632 1.00 PTPN1 (0.56) PTPN1MEN1KMT2APOLBALOX15
SCHEMBL29954142 0.84 PTPN1 (0.54) PTPN1MEN1KMT2APOLBALOX15
SCHEMBL21591443 0.73 PTPN1 (0.56) PTPN1MEN1KMT2APOLBMAOA
SCHEMBL10994834 0.73 ALOX15 (0.59) MEN1KMT2APOLBALOX15ALOX12
SCHEMBL11151168 0.72 ALOX15 (0.55) MEN1KMT2AALOX15ALOX12XDH
SCHEMBL234354 0.72 ALOX15 (0.75) MEN1KMT2AALOX15ALOX12XDH
SCHEMBL11872015 0.72 PTPN1 (1.00) PTPN1MEN1KMT2APOLBGAA
SCHEMBL29950744 0.72 PTPN1 (1.00) PTPN1MEN1KMT2APOLBGAA
SCHEMBL30533224 0.71 XDH (1.00) MEN1KMT2AALOX15ALOX12XDH
SCHEMBL28705298 0.71 ALOX15 (0.73) MEN1KMT2AALOX15ALOX12XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101528758-B [(4-oxo-4h-chromen-3-yl)-hydroxy methyl]- or [(4-oxo-4h-chromen-3-yl)-methyl]-phosphonic acid derivates MERCK PATENT GMBH 2012-06-13 — — CN disclosed
US-8052963-B2 [(4-oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-11-08 — — US disclosed
US-8052963-B2 [(4-oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-11-08 — — US disclosed
US-8052963-B2 [(4-oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-11-08 — — US disclosed
EP-1979337-B1 CHROMEN-4-ONE DERIVATIVES AS A SELF-TANNING SUBSTANCE MERCK PATENT GMBH (DE) 2011-05-25 — — EP disclosed
EP-2134732-B1 [(4-OXO-4H-CHROMEN-3-YL)-HYDROXY METHYL]- OR [(4-OXO-4H-CHROMEN-3-YL)-METHYL]-PHOSPHONIC ACID DERIVATES MERCK PATENT GMBH (DE) 2010-11-24 — — EP disclosed
EP-2134732-B1 [(4-OXO-4H-CHROMEN-3-YL)-HYDROXY METHYL]- OR [(4-OXO-4H-CHROMEN-3-YL)-METHYL]-PHOSPHONIC ACID DERIVATES MERCK PATENT GMBH (DE) 2010-11-24 — — EP disclosed
US-20100004209-A1 [(4-Oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives MERCK PATENT GESELLSCHAFT (DE) 2010-01-07 — — US disclosed
US-20100004209-A1 [(4-Oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives MERCK PATENT GESELLSCHAFT (DE) 2010-01-07 — — US disclosed
US-20100004209-A1 [(4-Oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives MERCK PATENT GESELLSCHAFT (DE) 2010-01-07 — — US disclosed
CN-101528758-A [(4-oxo-4h-chromen-3-yl)-hydroxy methyl]- or [(4-oxo-4h-chromen-3-yl)-methyl]-phosphonic acid derivates MERCK PATENT GMBH (DE) 2009-09-09 — — CN disclosed
US-20090220438-A1 CHROMEN-4-ONE DERIVATIVES AS SELF-TANNING SUBSTANCE MERCK PATENT GMBH (DE) 2009-09-03 — — US disclosed
EP-1979337-A1 CHROMEN-4-ONE DERIVATIVES AS A SELF-TANNING SUBSTANCE Merck Patent GmbH (DE) 2008-10-15 — — EP disclosed
WO-2008052631-A1 [(4-OXO-4H-CHROMEN-3-YL)-HYDROXY METHYL]- OR [(4-OXO-4H-CHROMEN-3-YL)-METHYL]-PHOSPHONIC ACID DERIVATES MERCK PATENT GMBH (DE) 2008-05-08 — — WO disclosed
WO-2007087956-A1 CHROMEN-4-ONE DERIVATIVES AS A SELF-TANNING SUBSTANCE MERCK PATENT GMBH (DE) 2007-08-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090220438-A1 CHROMEN-4-ONE DERIVATIVES AS SELF-TANNING SUBSTANCE C9, CYP8B1, TYR PTPN1 4281/4885MEN1 965/4885KMT2A 2386/4885
US-20100004209-A1 [(4-Oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid derivatives H1-4, H1-0, H1-5 PTPN1 720/4885MEN1 318/4885KMT2A 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback